Remi Gaston-Dreyfus - Mar 26, 2021 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Stock symbol
BNKL
Transactions as of
Mar 26, 2021
Transactions value $
$0
Form type
4
Date filed
12/13/2021, 03:30 PM
Next filing
Dec 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Purchase +136K +10.57% 1.42M Mar 26, 2021 Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA F1
holding BNKL Common Stock, par value $0.001 per share 61.3K Mar 26, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person, through its affiliate RGD Investissements S.A.S., acquired the shares of common stock for consideration consisting of the forgiveness and satisfaction of an aggregate of $338,904 of wage liabilities of the Issuer's subsidiaries.